A Study to Investigate the Safety, Reactogenicity, and Immunogenicity of a Vaccine to prevent Ebola-Bundibugyo Virus Disease
For demographics: Adults
Purpose
About Bundibugyo Ebolavirus
Participation Criteria
Participation Details
More studies:
A Study to Investigate the Safety, Reactogenicity, and Immunogenicity of a Vaccine to prevent Ebola-Bundibugyo Virus Disease
August 6, 2026
Immune Profiling and Biospecimen Collection in Acute Epstein-Barr Virus Infection
May 12, 2026
Clinical Trial of a Plant-Based Seasonal Influenza Vaccine in Adults
February 27, 2026
Phase 2 Clinical Trial Evaluating an Inhaled Aerosol COVID-19 Vaccine
January 22, 2026
Influenza Controlled Human Infection Model (“FluCHIM”)
November 19, 2025
Controlled Human Infection Model: Bordetella pertussis
October 24, 2025
CosTaR – Tdap and RSV vaccines in pregnancy phase 4 pilot feasibility trial
September 24, 2025
Partnering with Young Men who have Sex with Men to Co-Design a User-Centered Digital Health Literacy Tool to Support Human Papillomavirus Vaccine (HPV) Decision Making
July 31, 2025